MDLN vs. JNJ

Last updated Jun 4, 2026

MDLN (Medline Inc) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — MDLN in Medical Instruments & Supplies, JNJ in Drug Manufacturers - General. At a 0.23 correlation, their price movements are largely independent.

Performance

MDLN vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medline Inc (MDLN) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MDLN achieves a -17.93% return, which is significantly lower than JNJ's 9.07% return.

MDLN

• 1D: 3.86%
• 1M: -22.00%
• YTD: -17.93%
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

JNJ

• 1D: 0.16%
• 1M: 0.14%
• YTD: 9.07%
• 6M: 9.93%
• 1Y: 48.18%
• 3Y*: 15.79%
• 5Y*: 9.14%
• 10Y*: 9.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MDLN vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025
MDLN Medline Inc	-17.93%	2.44%
JNJ Johnson & Johnson	9.07%	-1.61%

Correlation

The correlation between MDLN and JNJ is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Dec 18, 2025	0.23

Fundamentals

Market Cap MDLN : $28.44B JNJ : $545.87B
EPS MDLN : $1.20 JNJ : $8.65
PE Ratio MDLN : 28.71 JNJ : 25.81
PEG Ratio MDLN : 0.14 JNJ : 0.86
PS Ratio MDLN : 0.95 JNJ : 5.64
PB Ratio MDLN : 2.52 JNJ : 6.72
Total Revenue (TTM) MDLN : $29.14B JNJ : $96.36B
Gross Profit (TTM) MDLN : $7.01B JNJ : $66.60B
EBITDA (TTM) MDLN : $2.95B JNJ : $31.62B

Return for Risk

MDLN vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ

JNJ Risk / Return Rank: 92
JNJ Sharpe Ratio Rank: 94
JNJ Sortino Ratio Rank: 95
JNJ Omega Ratio Rank: 93
JNJ Calmar Ratio Rank: 89
JNJ Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDLN vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medline Inc (MDLN) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	MDLN	JNJ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.91	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.55	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.54	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.75	0.53	-1.29

Drawdowns

MDLN vs. JNJ - Drawdown Comparison

The maximum MDLN drawdown since its inception was -33.61%, smaller than the maximum JNJ drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for MDLN and JNJ.

Drawdown Indicators

	MDLN	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-33.61%	-50.67%	+17.06%
Max Drawdown (1Y) Largest decline over 1 year	—	-10.96%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-15.95%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-18.41%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-27.37%	—
Current Drawdown Current decline from peak	-31.05%	-9.67%	-21.38%
Average Drawdown Average peak-to-trough decline	-10.36%	-11.88%	+1.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.63%	—

Volatility

Volatility by Period

	MDLN	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.20%	—
Volatility (6M) Calculated over the trailing 6-month period	—	12.17%	—
Volatility (1Y) Calculated over the trailing 1-year period	42.57%	16.67%	+25.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.57%	16.82%	+25.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.57%	18.45%	+24.12%

Dividends

MDLN vs. JNJ - Dividend Comparison

MDLN has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.35%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JNJ Johnson & Johnson	2.35%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%
MDLN Medline Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

MDLN vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Medline Inc and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MDLN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medline Inc reported a gross profit of 1.67B and revenue of 7.35B. Therefore, the gross margin over that period was 22.7%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

MDLN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medline Inc reported an operating income of 422.00M and revenue of 7.35B, resulting in an operating margin of 5.7%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

MDLN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medline Inc reported a net income of 129.00M and revenue of 7.35B, resulting in a net margin of 1.8%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

Frequently Asked Questions

Can I hold both MDLN and JNJ in my portfolio?

MDLN and JNJ have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.